Skip to main content

Published locations for Drug combo extends survival by more than 1 year in metastatic prostate cancer patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Drug combo extends survival by more than 1 year in metastatic prostate cancer patients

User login

  • Reset your password
  • /content/drug-combo-extends-survival-more-1-year-metastatic-prostate-cancer-patients
  • /familypracticenews/article/82798/genitourinary-cancer/drug-combo-extends-survival-more-1-year
  • /internalmedicinenews/article/82798/genitourinary-cancer/drug-combo-extends-survival-more-1-year
  • /oncologypractice/article/82798/genitourinary-cancer/drug-combo-extends-survival-more-1-year
  • /hematology-oncology/article/82798/genitourinary-cancer/drug-combo-extends-survival-more-1-year
  • /internalmedicine/article/82798/genitourinary-cancer/drug-combo-extends-survival-more-1-year
  • /familymedicine/article/82798/genitourinary-cancer/drug-combo-extends-survival-more-1-year-metastatic